youtube_live
Q4 2026 earnings • released • EPS miss -56.95% • Revenue beat +2.44%
See resultschevron_right
TWST:NASDAQ
Twist Bioscience Corp
$114.22
arrow_downward
-6.83%(-8.37) 1D
$113.50
arrow_downward
-0.63% (-0.72)todayPre-market
Closed: Nov 12, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$99.72
High
$114.97
Low
$93.68
Mkt. cap
7.57B
Avg. vol.
2.82M
Volume
1.44K
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.25
Shares outstanding
65.83M
No. of employees
979
Open
$99.72
High
$114.97
Low
$93.68
Mkt. cap
7.57B
Avg. vol.
2.82M
Volume
1.44K
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.25
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
Investing.com
·
9 hours ago
Cathie Wood’s ARK sells Amazon stock, buys CoreWeave and Twist Bioscience
Investor's Business Daily
·
13 hours ago
The Guidance Twist That Sent This AI-Tied Biotech Into Free Fall
Yahoo Finance
·
13 hours ago
Twist Bioscience: 3 Key Takeaways for Long-Term Investors
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp
CEOEmily LeProust
Employees979
Founded2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitetwistbioscience.com